Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Genetic prion diseases represent 10-15% of all prion diseases.
• The pathogenicity of shorter octapeptide repeat insertions, like the 2-octapeptide repeat variant, remains unclear.
• Understanding the clinical and genetic implications of these variants is crucial for accurate diagnosis and risk assessment.

Purpose of the Study:

• To characterize the 2-octapeptide repeat insertion genetic variant in prion disease.
• To assess the risk of developing Creutzfeldt-Jakob disease in asymptomatic carriers of this variant.
• To evaluate the clinical presentation and prion protein characteristics associated with the 2-octapeptide repeat insertion.

Main Methods:

• Case series analysis of patients with 2-octapeptide repeat insertion prion disease from international registries.
• Querying large-scale population genetic databases to determine the allele frequency of the 2-octapeptide repeat insertion.
• Western blot analysis of prion protein profiles in affected individuals.

Main Results:

• Eight cases of 2-octapeptide repeat insertion prion disease were identified.
• Clinical presentation of these cases was indistinguishable from sporadic Creutzfeldt-Jakob disease (sCJD) of the same molecular subtype.
• Western blot analysis revealed distinct prion protein profiles for 2-octapeptide repeat insertion and sCJD.
• Population data indicated a very low penetrance for the 2-octapeptide repeat insertion variant.

Conclusions:

• The 2-octapeptide repeat insertion is associated with prion disease but appears to be a low-risk genetic variant.
• Asymptomatic carriers have a low risk of developing Creutzfeldt-Jakob disease.
• Predictive genetic testing for asymptomatic relatives is generally not justified due to the low penetrance.